KASL clinical practice guidelines for management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

doi:10.3350/cmh.2022.0084

KASL clinical practice guidelines for management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Department of Internal Medicine

Yonsei University
Seoul National University
Sungkyunkwan University
CHA University
Korea University
University of Ulsan
Hanyang University

Research output: Contribution to journal › Article › peer-review

118 Scopus citations

Original language	English
Pages (from-to)	276-331
Number of pages	56
Journal	Clinical and Molecular Hepatology
Volume	28
Issue number	2
DOIs	https://doi.org/10.3350/cmh.2022.0084
State	Published - Apr 2022

Bibliographical note

Funding Information:
Jang JW: Received honoraria from Gilead, Abbvie, Bayer, Roche, Sysmex, Ipsen. Received grants from Sysmex, Gilead, Yuhan, Dong-A ST, Hanmi Park JY: Received grants from Gilead, Pfizer, MSD, BMS, Roche, Astrazeneca, Aramchol, Novonorodisk, Yuhan, Hanmi Kwon JH: Received honoraria and grants from Gilead, Abbvie Yu SJ: Received honoraria and grants from Gilead, Abbvie, BMS, Daewoong, Yuhan, Chongkundang Pharm, Dong-A ST, Samil, Samjin Kang W: Received honoraria and grants from Gilead, BMS, Ab-

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Chronic hepatitis B
Disease management
KASL guidelines
Therapeutics
Treatment

Access to Document

10.3350/cmh.2022.0084

Cite this

@article{6bf09d90c9204959a99af82567e4b482,

title = "KASL clinical practice guidelines for management of chronic hepatitis B",

keywords = "Chronic hepatitis B, Disease management, KASL guidelines, Therapeutics, Treatment",

author = "\{The Korean Association for the Study of the Liver (KASL)\} and Jang, \{Jeong Won\} and Park, \{Jun Yong\} and Kwon, \{Jung Hyun\} and Yu, \{Su Jong\} and Wonseok Kang and Chon, \{Young Eun\} and Kim, \{Tae Hyung\} and Jonggi Choi and Jihyun An",

note = "Funding Information: Jang JW: Received honoraria from Gilead, Abbvie, Bayer, Roche, Sysmex, Ipsen. Received grants from Sysmex, Gilead, Yuhan, Dong-A ST, Hanmi Park JY: Received grants from Gilead, Pfizer, MSD, BMS, Roche, Astrazeneca, Aramchol, Novonorodisk, Yuhan, Hanmi Kwon JH: Received honoraria and grants from Gilead, Abbvie Yu SJ: Received honoraria and grants from Gilead, Abbvie, BMS, Daewoong, Yuhan, Chongkundang Pharm, Dong-A ST, Samil, Samjin Kang W: Received honoraria and grants from Gilead, BMS, Ab-",

year = "2022",

month = apr,

doi = "10.3350/cmh.2022.0084",

language = "English",

volume = "28",

pages = "276--331",

journal = "Clinical and Molecular Hepatology",

issn = "2287-2728",

publisher = "Korean Association for the Study of the Liver",

number = "2",

}

TY - JOUR

T1 - KASL clinical practice guidelines for management of chronic hepatitis B

AU - The Korean Association for the Study of the Liver (KASL)

AU - Jang, Jeong Won

AU - Park, Jun Yong

AU - Kwon, Jung Hyun

AU - Yu, Su Jong

AU - Kang, Wonseok

AU - Chon, Young Eun

AU - Kim, Tae Hyung

AU - Choi, Jonggi

AU - An, Jihyun

N1 - Funding Information: Jang JW: Received honoraria from Gilead, Abbvie, Bayer, Roche, Sysmex, Ipsen. Received grants from Sysmex, Gilead, Yuhan, Dong-A ST, Hanmi Park JY: Received grants from Gilead, Pfizer, MSD, BMS, Roche, Astrazeneca, Aramchol, Novonorodisk, Yuhan, Hanmi Kwon JH: Received honoraria and grants from Gilead, Abbvie Yu SJ: Received honoraria and grants from Gilead, Abbvie, BMS, Daewoong, Yuhan, Chongkundang Pharm, Dong-A ST, Samil, Samjin Kang W: Received honoraria and grants from Gilead, BMS, Ab-

PY - 2022/4

Y1 - 2022/4

KW - Chronic hepatitis B

KW - Disease management

KW - KASL guidelines

KW - Therapeutics

KW - Treatment

UR - https://www.scopus.com/pages/publications/85129710875

U2 - 10.3350/cmh.2022.0084

DO - 10.3350/cmh.2022.0084

M3 - Article

AN - SCOPUS:85129710875

SN - 2287-2728

VL - 28

SP - 276

EP - 331

JO - Clinical and Molecular Hepatology

JF - Clinical and Molecular Hepatology

IS - 2

ER -

KASL clinical practice guidelines for management of chronic hepatitis B

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Cite this